Science Explorer Back to mapMap
Discussion

Ocuphire Pharma (United States)

Research works
3
▲ 19% vs 2018-21
Citations
8
3.0 per fractional work
Top-10% rate
2.8%
all institutions 10.0%
Open access
90%
world 40%
International
22%
world 18%

Not ranked overall: Ocuphire Pharma (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Ocuphire Pharma (United States) work in?

In all years, 64% of research at Ocuphire Pharma (United States) is in Health Sciences, 36% in Life Sciences. Its largest fields are Medicine (64%), Neuroscience (25%), Biochemistry, Genetics and Molecular Biology (11%). It does 1.3× the world's share of Health Sciences.

Life Sciences36%Health Sciences64%

Each ring splits the one inside it: the four domains of science, their fields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 2 domains and 3 fields, with their numbers
    1. Medicine264.3%
    1. Neuroscience125.0%
    2. Biochemistry, Genetics and Molecular Biology010.7%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Who are the top researchers at Ocuphire Pharma (United States)?

Ranked on the quality score, Mina Sooch lead among researchers whose main affiliation is Ocuphire Pharma (United States).

  1. 1 Mina Sooch United States · #4,249,672 worldwide 163 citations · 18 works
All ranked researchers at Ocuphire Pharma (United States)

What are the most cited papers from Ocuphire Pharma (United States)?

The most cited paper from Ocuphire Pharma (United States) is "APE1/Ref-1 as a Novel Target for Retinal Diseases" (Curtis J. Heisel, Jonah E. Yousif, Mahmut Mijiti et al., 2021), with 20 citations. Next come "Phentolamine Mesylate Ophthalmic Solution Provides Lasting Pupil Modulation and Improves Near Visual Acuity in Presbyopic Glaucoma Patients in a Randomized Phase 2b Clinical Trial" (12) and "Prevalence Estimates and Genetic Diversity for Autosomal Dominant Retinitis Pigmentosa Due to RHO, c.68C>A (p.P23H) Variant" (8).

Most cited papers
#PaperReleasedCitations
1 APE1/Ref-1 as a Novel Target for Retinal Diseases Curtis J. Heisel, Jonah E. Yousif, Mahmut Mijiti et al. · Journal of Cellular Signaling Open access 30 Jun 2021 20
2 Phentolamine Mesylate Ophthalmic Solution Provides Lasting Pupil Modulation and Improves Near Visual Acuity in Presbyopic Glaucoma Patients in a Randomized Phase 2b Clinical Trial Jay S. Pepose, Paul J. Hartman, Harvey B. Dubiner et al. · Clinical ophthalmology Open access 2021 12
3 Prevalence Estimates and Genetic Diversity for Autosomal Dominant Retinitis Pigmentosa Due to RHO, c.68C>A (p.P23H) Variant Matthijs Leenders, Mathijs Gaastra, Ash Jayagopal et al. · American Journal of Ophthalmology 14 Sep 2024 8
4 A randomized phase 2 clinical trial of phentolamine mesylate eye drops in patients with severe night vision disturbances Jay S. Pepose, Mitchell Brigell, Eliot S. Lazar et al. · BMC Ophthalmology Open access 8 Oct 2022 5
5 Phentolamine Eye Drops Reverse Pharmacologically Induced Mydriasis in a Randomized Phase 2b Trial Paul M Karpecki, Shane A. Foster, Stephen M. Montaquila et al. · Optometry and Vision Science 27 Feb 2021 5
All 11 most cited papers, with filters and sorting

Which research topics does Ocuphire Pharma (United States) publish most on?

By volume in 2022-now: Ophthalmology and Visual Impairment Studies, Retinal Development and Disorders, Hereditary Neurological Disorders and Genetic Neurodegenerative Diseases.

  1. 1 Ophthalmology and Visual Impairment Studies Epidemiology 0 works
  2. 2 Retinal Development and Disorders Molecular Biology 0 works
  3. 3 Hereditary Neurological Disorders Cellular and Molecular Neuroscience 0 works
  4. 4 Genetic Neurodegenerative Diseases Cellular and Molecular Neuroscience 0 works
  5. 5 Circadian rhythm and melatonin Endocrine and Autonomic Systems 0 works
  6. 6 Ocular Surface and Contact Lens Public Health, Environmental and Occupational Health 0 works
  7. 7 Ocular and Laser Science Research Ophthalmology 0 works
  8. 8 Biomedical Research and Pathophysiology Pathology and Forensic Medicine 0 works
  9. 9 Glaucoma and retinal disorders Ophthalmology 0 works
  10. 10 Corneal surgery and disorders Radiology, Nuclear Medicine and Imaging 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available90.5%not open9.5%

World: 40% of research is openly available.

with international co-authors21.8%domestic only78.2%

World: 18% is written across borders.

How has Ocuphire Pharma (United States)'s research output changed?

Output in 2022-2025 was 19% higher than in 2018-2021.

still counting2025

Other research institutions in Farmington Hills

All research institutions in Farmington Hills

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Ocuphire Pharma (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.